Elite Pharmaceuticals Inc
What this means
- In the filings we classify there is no bankruptcy, debt default, delisting notice, late filing notice or restatement for this company.
What to do next
- How to check a US company before you sign a contractguide
- How to read an 8-K: what customers and creditors should checkguide
Guides from the Companies Daily newsroom, picked for what the register shows.
Financials from XBRL
| Calendar-year frame | 2025 | 2024 |
|---|---|---|
| Revenue | $149M | $84M |
| Net income (loss) | $44.9M | −$4.3M |
| Total assets | $126M | $90.8M |
| Total liabilities | $46.1M | $54.3M |
| Stockholders’ equity | $80.3M | $36.4M |
| Cash and equivalents | $21.6M | $8.7M |
From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends March 31. Check the annual report for the exact figures and periods.
- Name as filed
- ELITE PHARMACEUTICALS INC /NV/
Formerly: Elite Pharmaceuticals Inc - CIK
- 0001053369
- Tickers
- ELTP
- Kind of filer
- SEC-reporting company
Non-accelerated filer; Smaller reporting company - Status
- Filing with the SEC
- State of incorporation
- New Jersey
- Business address
- Northvale, New Jersey
- Industry (SIC)
- 2834 · Pharmaceutical preparations
Industry: D · Manufacturing → - Fiscal year ends
- March 31
- Last annual report
- 10-K for the period ended Mar 31, 2026
- Last quarterly report
- 10-Q for the quarter ended Sep 30, 2026
- Bankruptcy reported
- Not in our data
- Last edition event
- Nov 12, 2026
Filing history
Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.
- Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
- Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
- Form 8-K · items 5.02, 7.01, 9.01 · filed Nov 3, 2026 · filing · edition of Nov 3, 2026
- Form 10-Q · filed Aug 13, 2026 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 13, 2026 · filing
- Form 10-K · filed Jun 29, 2026 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Jun 29, 2026 · filing
- Form 10-Q · filed Feb 17, 2026 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Feb 17, 2026 · filing
- Form 10-Q · filed Nov 14, 2025 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 14, 2025 · filing
- Form 10-Q · filed Aug 14, 2025 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 14, 2025 · filing
- Form 10-K · filed Jun 30, 2025 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Jun 30, 2025 · filing
- Form 10-Q · filed Feb 13, 2025 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Feb 13, 2025 · filing
- Form 10-Q · filed Nov 14, 2024 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 14, 2024 · filing
- Form 10-Q · filed Aug 14, 2024 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 14, 2024 · filing
- Form 10-K · filed Jul 1, 2024 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Jul 1, 2024 · filing
- Form 8-K · items 4.01, 9.01 · filed Jun 5, 2024 · filing
- Form 10-Q · filed Feb 14, 2024 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Feb 14, 2024 · filing
- Form 10-Q · filed Nov 14, 2023 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 14, 2023 · filing
- Form 8-K · items 1.01, 5.02, 9.01 · filed Sep 7, 2023 · filing
- Form 10-Q · filed Aug 14, 2023 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 14, 2023 · filing
- Form 8-K · items 4.01, 9.01 · filed Jul 17, 2023 · filing
- Form 10-K · filed Jun 29, 2023 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Jun 29, 2023 · filing
- Form 8-K · items 1.01, 5.02, 9.01 · filed May 3, 2023 · filing
- Form 8-K · items 5.02 · filed Feb 28, 2023 · filing
- Form 10-Q · filed Feb 14, 2023 · filing
- Form 8-K · items 2.02, 7.01, 9.01 · filed Feb 14, 2023 · filing